Sale

Alopecia Market

Global Alopecia Market Share, Size, Growth, Analysis: By Disease Type: Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis, Others; By Treatment: Localized Therapies, Systemic Therapies, Others; By Route of Administration; By Gender; By Distributional Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Alopecia Market Outlook

The global alopecia market size attained a value of USD 3.58 billion in 2023. The major driver of the market includes the increasing occurrences of polycystic ovary syndrome, cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses. The market is anticipated to grow at a CAGR of 8.6% during the forecast period of 2024-2032 to attain a value of USD 7.53 billion by 2032.

 

Global Alopecia Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

There are many different kinds of alopecia, each with a distinct cause. As is prevalent in male pattern baldness, alopecia can be located at the front and top of the head. It may be patchy as in an alopecia areata disorder. The alopecia market can be divided on the basis of segments like disease type, drug type, route of administration, gender, and distribution channel.

 

Global Alopecia Market By Drug Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global alopecia market can be broadly categorised on the basis of disease type into:

  • Androgenic Alopecia
  • Alopecia Areata
  • Ciatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis

The industry can be divided on the basis of drug type as:

  • Minoxidil
  • Finasteride
  • Others

The global alopecia market can be categorised based on route of administration as:

  • Oral
  • Topical
  • Injectable

The industry can be divided based on gender as:

  • Males
  • Females

The global alopecia market can be divided on the basis of the distribution channel as:

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

The EMR report looks into the regional markets of alopecia like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Alopecia Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Alopecia Market Analysis

It is expected that the occurrence of Polycystic Ovary Syndrome (PCOS), cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses will drive the global alopecia market. Changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods and increased concentrations of stress are regarded as powerful triggers for alopecia. While the precise causative factors stay unknown, genetic factors are associated with several instances. Increasing disposable earnings and increasing emphasis on aesthetic appearances are anticipated to contribute to the demand for therapy of alopecia. Hormonal imbalance and ageing accelerate the growth of hair loss instances, further aiding the global alopecia market growth. The overall increase in the geriatric population and rising customer consciousness of therapy alternatives are also anticipated to have a positive impact on the global alopecia market in the following years. During the forecast period, the product development of new therapeutic alternatives is anticipated to drive the industry growth. Other factors driving the industry include the introduction of fast-acting JAK inhibitors, the development of techniques to boost hair growth using human pluripotent stem cells, and PRP therapy.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global alopecia market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Cipla Ltd.
  • Capillus LLC
  • Freedom Laser Therapy, Inc.
  • Apira Science, Inc.
  • HairMax (Lexington Intl., LLC)
  • Follica, Inc.
  • Incyte Corporation
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Disease Type
  • Treatment
  • Route of Administration
  • Gender
  • Distribution Channel
  • End User
  • Region
Breakup by Disease Type
  • Androgenic Alopecia
  • Alopecia Areata
  • Cicatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis
  • Others
Breakup by Treatment
  • Localized Therapies
  • Systemic Therapies
  • Medical Devices
  • Herbal Treatment
  • Others
Breakup by Route of Administration
  • Oral
  • Topical
  • Parenteral
Breakup by Gender
  • Males
  • Female
Breakup by Distribution Channel
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
Breakup by End User
  • Hospitals
  • Healthcare and Dermatology Centers
  • Homecare
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Cipla Ltd.
  • Capillus LLC
  • Freedom Laser Therapy, Inc.
  • Apira Science, Inc.
  • HairMax (Lexington Intl., LLC)
  • Follica, Inc.
  • Incyte Corporation
  • Novartis International AG
  • Sanofi S.A.
  • Merck & Co. Inc.
  • Gerolymatos International SA
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • WOCKHARDT
  • Teva Pharmaceuticals USA, Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Alopecia Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Alopecia Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Alopecia Epidemiology (2016-2031)
    5.3    Europe Alopecia Epidemiology (2016-2031)
    5.4    Asia-Pacific Alopecia Epidemiology (2016-2031)
    5.5    Latin America Alopecia Epidemiology (2016-2031)
    5.6    Middle East & Africa Alopecia Epidemiology (2016-2031)
6    Global Alopecia Market Overview 
    6.1    Global Alopecia Market Historical Value (2017-2023)
    6.2    Global Alopecia Market Forecast Value (2024-2032)
7    Global Alopecia Market Landscape
    7.1    Alopecia: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Alopecia: Product Landscape
        7.2.1    Analysis by Type Disease
        7.2.2    Analysis by Treatment
        7.2.3    Analysis by Applications
        7.2.4    Analysis by Route of Administration
        7.2.5    Analysis by Gender
        7.2.6    Analysis by Distribution Channel
        7.2.7    Analysis by End User
8    Alopecia Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Alopecia Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Alopecia Market Segmentation
    11.1    Global Alopecia Market by Disease Type
        11.1.1    Market Overview
        11.1.2    Androgenic Alopecia
        11.1.3    Alopecia Areata
        11.1.4    Cicatricial Alopecia
        11.1.5    Traction Alopecia
        11.1.6    Alopecia Totalis
        11.1.7    Others
    11.2    Global Alopecia Market by Treatment
        11.2.1    Market Overview
        11.2.2    Localized Therapies
        11.2.3    Systemic Therapies
        11.2.4    Medical Devices
        11.2.5    Herbal Treatment
        11.2.6    Others
    11.3    Global Alopecia Market by Route of Administration
        11.3.1    Market Overview
        11.3.2    Oral
        11.3.3    Topical
        11.3.4    Parenteral 
    11.4    Global Alopecia Market by Gender
        11.4.1    Market Overview
        11.4.2    Males
        11.4.3    Female
    11.5    Global Alopecia Market by Distribution Channel
        11.5.1    Market Overview
        11.5.2    Hospitals
        11.5.3    Retail Pharmacies
        11.5.4    Online Pharmacies
    11.6    Global Alopecia Market by End User
        11.6.1    Market Overview
        11.6.2    Hospitals
        11.6.3    Healthcare and Dermatology Centers
        11.6.4    Homecare
        11.6.5    Others
    11.7    Global Alopecia Market by Region
        11.7.1    Market Overview
        11.7.2    North America
        11.7.3    Europe 
        11.7.4    Asia Pacific
        11.7.5    Latin America
        11.7.6    Middle East and Africa
12    North America Alopecia Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Alopecia Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Alopecia Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Alopecia Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Alopecia Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    Cipla Ltd.
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Capillus LLC
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Freedom Laser Therapy, Inc.
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Apira Science, Inc.
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    HairMax (Lexington Intl., LLC)
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Follica, Inc.
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Incyte Corporation
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Novartis International AG
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    Sanofi S.A.
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Merck & Co. Inc.
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    Gerolymatos International SA
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
    23.12    Taisho Pharmaceutical Holdings Co., Ltd.
        23.12.1    Financial Analysis
        23.12.2    Product Portfolio
        23.12.3    Demographic Reach and Achievements
        23.12.4    Mergers and Acquisitions
        23.12.5    Certifications
    23.13    Dr. Reddy’s Laboratories Ltd.
        23.13.1    Financial Analysis
        23.13.2    Product Portfolio
        23.13.3    Demographic Reach and Achievements
        23.13.4    Mergers and Acquisitions
        23.13.5    Certifications
    23.14    WOCKHARDT
        23.14.1    Financial Analysis
        23.14.2    Product Portfolio
        23.14.3    Demographic Reach and Achievements
        23.14.4    Mergers and Acquisitions
        23.14.5    Certifications
    23.15    Teva Pharmaceuticals USA, Inc.
        23.15.1    Financial Analysis
        23.15.2    Product Portfolio
        23.15.3    Demographic Reach and Achievements
        23.15.4    Mergers and Acquisitions
        23.15.5    Certifications
24    Alopecia - Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

Globally, alopecia market reached a value of USD 3.58 billion in 2023.

The market is projected to expand at a CAGR of 8.6% from 2024 to 2032, growing to USD 7.53 billion by 2032.

The major driver of the market includes the increasing occurrences of polycystic ovary syndrome, cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses.

Changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods and increased concentrations of stress are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

The major disease types of alopecia in the market are androgenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis.

The significant drug types in the industry are minoxidil and finasteride, among others.

The leading routes of administration in the market are oral, topical, and injectable.

The major gender segments in the industry are males and females.

The significant distribution channels in the market are hospitals, retail pharmacies, and online pharmacies.

The major players in the industry are Cipla Ltd., Capillus LLC, Freedom Laser Therapy, Inc., Apira Science, Inc., HairMax (Lexington Intl., LLC), Follica, Inc., and Incyte Corporation, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER